[1] |
ZHANG Pei-ze, ZHENG Jun-feng, CAO Wei-peng, WANG Yu-xiang, CHEN Tao, FU Liang, DENG Guo-fang.
Study of the serum concentration at two time points after taking rifampicin
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 493-497.
|
[2] |
ZHAO Jiao-jie,FU Lei,WANG Bin,ZHANG Lei,HU Ming-hao,LU Yu.
Establishment and application of pharmacodynamics and pharmacokinetics model in vitro
[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 372-379.
|
[3] |
LIU Er-yong, ZHOU Lin, XUE Xiao, LIU Chun-fa, BAI Li-qiong, LU Wei, ZHANG Tian-hua, CHENG Shi-ming.
Evaluation of treatment effect and safety of rifampicin capsule (Ⅱ) on pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1092-1099.
|
[4] |
Xi CHEN,Zhong-quan LIU,Bin WANG,Hui ZHU,Lei FU,Yuan-yuan LI,Yu LU.
Evaluation of antituberculosis activities of 14 antituberculosis drugs in macrophage
[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 993-998.
|
[5] |
Ming-wu LI,Ming-hong LAI,Meng MA,Rong WAN,Yuan XU,Chao-mei DU.
Analysis on the monitoring results of plasma-drug concentration of rifampicin in different dosage forms
[J]. Chinese Journal of Antituberculosis, 2019, 41(6): 645-649.
|
[6] |
Jiao-jie ZHAO,Yu LU.
Research and progress of PK/PD for anti-tuberculosis drugs
[J]. Chinese Journal of Antituberculosis, 2019, 41(6): 700-704.
|
[7] |
Yuan LIU,Jun ZHOU,Xiao-li CUI,Jia-yuan LEI,Guo-lian ZHAO,Li-yun DANG.
The relationship between false-positive rifampicin resistant results of GeneXpert MTB/RIF and very low bacterial load in the clinical samples
[J]. Chinese Journal of Antituberculosis, 2019, 41(2): 176-180.
|
[8] |
YANG Shuang,GUO Jing-wei,HU Yi-min,TAN Yun-hong,TAN Xiao,YUAN Shi-shan.
Screening and identification of serological diagnostic antigens for tuberculosis
[J]. Chinese Journal of Antituberculosis, 2019, 41(11): 1217-1222.
|
[9] |
Shao-chen GUO,Hui ZHU,Chao GUO,Bin WANG,Zhong-quan LIU,Jian XU,Lei FU,Xiao-you CHEN,Yu LU.
Analysis of plasma concentrations of first-line anti-tuberculosis drugs in 909 tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2018, 40(7): 744-749.
|
[10] |
Qi-hui LIU,Feng SUN,Tao SUN,Xiao-fang JIA,Fei-fei SU,Ji-chan SHI,Li-jun ZHANG,Xian-gao JIANG,Wen-hong. ZHANG.
The relationship between plasma concentrations of the first-line anti-tuberculosis drugs and sputum negative conversion at early stage
[J]. Chinese Journal of Antituberculosis, 2018, 40(2): 157-160.
|
[11] |
ZHU Hui,LIU Zhong-quan,XIE Li,GUO Shao-chen,WANG Bin,FU Lei,LU Yu.
Determination of bedaquiline plasma concentration by high performance liquid chromatography-mass spectrometry/mass spectrometry
[J]. Chinese Journal of Antituberculosis, 2018, 40(12): 1319-1324.
|
[12] |
ZHOU Lin, WANG Ni, LIU Er-yong, LAI Yu-ji, CHEN Ming-ting, HE Jin-ge, GENG Hong, ZHANG Lian-ying, YUAN Yan-li, YANG Shu-min.
Analysis of liver injury in 5981 pulmonary tuberculosis patients treated with FDC
[J]. Chinese Journal of Antituberculosis, 2014, 36(4): 256-259.
|
[13] |
ZHANG Yan,ZHANG Jin-guo,FANG Deng-lou,ZHANG Yong-qiang,ZHANG Bao-zong.
Analysis of clinical effect of alternate day therapy with fixed-dose combinations of anti-tuberculosis drugs
[J]. Chinese Journal of Antituberculosis, 2014, 36(1): 41-45.
|
[14] |
ZHU Hui, WANG Bin, FU Lei, LIU Cheng-cheng, LU Yu.
Pharmacokinetics comparison of pyrazinamide once and three times daily in mice and its influence on isoniazid-rifampicin
[J]. Chinese Journal of Antituberculosis, 2013, 35(12): 983-987.
|
[15] |
JIN Hai-xia, FU Lei, WANG Bin, ZHENG Mei-qin, LU Yu.
Study on the rifampicin-dependent characteristics of Mycobacterium tuberculosis clinical isolate
[J]. Chinese Journal of Antituberculosis, 2012, 34(10): 670-675.
|